Ratings by BTIG (Kambiz Yazdi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/20/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 9/1/2026 | Kazia Therapeutics | KZIA | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2026 | Sionna Therapeutics | SION | Downgrade | Neutral (Buy) |
51.04 (3.60) |
-92.95% | Details | |
| 7/28/2026 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2026 | Kazia Therapeutics | KZIA | New Coverage | Buy (N/A) |
14.08 (7.81) |
-44.53% | Details | |
| 6/9/2026 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2026 | Absci Corp. | ABSI | New Coverage | Buy (N/A) |
5.16 (9.18) |
77.91% | Details | |
| 4/14/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | vTv Therapeutics | VTVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Zevra Therapeutics, Inc. | ZVRA | New Coverage | Buy (N/A) |
9.98 (9.81) |
-1.7% | Details | |
| 3/11/2026 | vTv Therapeutics | VTVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2025 | Sionna Therapeutics | SION | New Coverage | Buy (N/A) |
39.93 (51.04) |
27.82% | Details | |
| 11/19/2025 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
25.11 (25.93) |
3.27% | Details | |
| 11/19/2025 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
197.58 (252.96) |
28.03% | Details | |
| 11/19/2025 | vTv Therapeutics | VTVT | New Coverage | Buy (N/A) |
30.15 (25.55) |
-15.26% | Details |
